Amplifon Logo

Amplifon

ISIN: IT0004056880 | Ticker: AMP | LEI: ZYXJDNVM2JI3VBM8G556
Sector: Health CareSub-Industry: Health Care Technology
Country: Italy

About Amplifon

Company Description

As the global leader in the hearing care retail industry, we have been changing the lives of millions of customers across the globe since 1950. With stores and offices spanning across 25 countries and a team of 18,600 dedicated professionals, we take pride in setting the industry standard as we empower people to rediscover all the emotions of sound.

Although we are constantly growing, we have the drive of a start-up and are committed to striving for innovation every day. Whatever role our employees take on at Amplifon, they each make more possible - more brands for customers, more support for colleagues, more opportunities for their own careers and more innovative possibilities. We are guided by our values and are motivated by our purpose, ensuring each new day brings opportunities for innovation as we explore new horizons for our business, our customers and each other. At Amplifon, we make more possible.

Served area

Worldwide

Headquarters

Via Ripamonti 131/133, 20141 Milano – Italy

Financial statements

Download as Excel
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Noncurrent Derivative Financial Assets N/A 10,983,000.00 25,850,000.00
Other Noncurrent Assets N/A 40,773,000.00 42,470,000.00
Current Trade Receivables N/A 168,680,000.00 192,067,000.00
Other Current Receivables N/A 91,555,000.00 72,610,000.00
Cash and cash equivalents 545,027,000.00 268,546,000.00 179,654,000.00
Current Derivative Financial Assets N/A 168,000.00 17,016,000.00
Retained Earnings Profit Loss For Reporting Period N/A 157,785,000.00 178,525,000.00
Retained Earnings Excluding Profit Loss For Reporting Period N/A 594,266,000.00 691,409,000.00
Noncurrent Contract Liabilities N/A 144,414,000.00 153,613,000.00
Noncurrent Derivative Financial Liabilities N/A 2,531,000.00 0.00
Other Noncurrent Liabilities N/A 16,318,000.00 16,123,000.00
Trade And Other Current Payables To Trade Suppliers N/A 242,507,000.00 325,583,000.00
Current Contract Liabilities N/A 107,414,000.00 114,857,000.00
Current Derivative Financial Liabilities N/A 552,000.00 0.00
Other Current Liabilities N/A 211,475,000.00 167,796,000.00
Line item in (eur) 01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Contracts With Customers 1,948,075,000.00 2,119,126,000.00
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 222,326,000.00 240,040,000.00
Profit (loss) 157,843,000.00 178,780,000.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 157,843,000.00 178,780,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A -279,876,000.00 -88,960,000.00
Cash and cash equivalents 545,027,000.00 268,546,000.00 179,654,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ITA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

IT0004056880

LEI

ZYXJDNVM2JI3VBM8G556

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Technology

Sub-Industry

Health Care Technology

Listed Stock Exchange

Borsa Italiana

Stock Index

FTSE MIB

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.